The current incarnation of the Food and Drug Administration (FDA) was established in 1930, but the US regulator’s modern functions …
The National Institute for health and Clinical Excellence (NICE) is a UK cost-effectiveness body that assesses a drug’s cost against …
The government’s plans for radical reform of the NHS has come under attack from doctors’ association the BMA, which says …
Research by Doctors.net.uk, on behalf of OTC Bulletin, has revealed that nine out of ten general practitioners in the UK …
Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …

NICE is now minded to approve Roche’s Herceptin for patients with metastatic gastric cancer after receiving new efficacy data from …
Genzyme’s chief executive Henri Termeer has signalled he will retire next year, a move which would help smooth the way …
Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …

Members of the European Parliament have voted in favour of giving patients across Europe access to ‘high quality information’ on …
Glasgow, UK-based contract research organisation ClinTec has expanded its US operations with the appointment of new executive vice president Dr …

It seems that barely a week goes by at the moment without news of another pharmaceutical company falling foul of …
Communicating with customers and patients digitally is top of many people’s agenda at the moment – it’s an exciting area …
A round-up of recent news from the CRO sector, featuring updates from CIT, Parexel, PPD, Cardialysis/Sticares and Porsolt. French non-clinical …
It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …
The NHS should use financial incentives to encourage people to make healthier lifestyle changes, according to NICE’s Citizen’s Council. The …
Grünenthal has been severely criticised in two rulings by UK pharma’s self-regulatory body the PMCPA for promoting off-label use of …
Pfizer has reduced the number of drugs in its product pipeline as part of a broad refocusing of its R&D …
There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …
Helvoet Pharma of Belgium has started officially started construction of a new production facility in India that is scheduled to …